Press "Enter" to skip to content

New patent for Janssen Biotech drug BALVERSA

1
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug BALVERSA

Annual Drug Patent Expirations for BALVERSA
Annual Drug Patent Expirations for BALVERSA

Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has eigthy patent family members in forty countries.

The generic ingredient in BALVERSA is erdafitinib. One supplier is listed for this compound. Additional details are available on the erdafitinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug BALVERSA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions